PLSE - PULSE BIOSCIENCES, INC.

14.48
-0.680   -4.696%

Share volume: 182,674
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$15.16
-0.68
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
16%
Profitability 8%
Dept financing 13%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.98%
1 Month
-16.03%
3 Months
-21.58%
6 Months
-8.01%
1 Year
92.30%
2 Year
280.05%
Key data
Stock price
$14.48
P/E Ratio 
0.00
DAY RANGE
$14.19 - $15.77
EPS 
-$1.12
52 WEEK RANGE
$6.60 - $25.00
52 WEEK CHANGE
$95.41
MARKET CAP 
1.075 B
YIELD 
N/A
SHARES OUTSTANDING 
61.290 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
BETA 
3.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$268,686
AVERAGE 30 VOLUME 
$229,718
Company detail
CEO: Kevin Danahy
Region: US
Website: pulsebiosciences.com
Employees: 140
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue.

Recent news
loading